AuntMinnie.com staff writersRadiation Oncology/TherapyFDA greenlights Varian's Flash clinical trialThe U.S. Food and Drug Administration (FDA) gave radiation therapy vendor Varian Medical Systems an investigational device exemption for the first-ever clinical trial of Flash therapy, an experimental treatment modality delivering radiation therapy at ultrahigh dose rates.October 12, 2020UltrasoundGE wins FDA clearance for AI cardiac ultrasound scannerGE Healthcare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Ultra Edition of its Vivid cardiovascular ultrasound scanner with artificial intelligence (AI) capabilities.October 11, 2020Advanced VisualizationUniversity of Rochester uses Vuzix's AR glassesVuzix has announced its augmented reality (AR) M400 Smart Glasses are being used by University of Rochester Medical Center surgeons for training.October 8, 2020Industry NewsSpectraWAVE appoints CEOSpectraWAVE has named Eman Namati, PhD, as CEO to lead the development and launch of the firm's photonic imaging system for coronary artery disease.October 8, 2020MRI1st patient implanted in Medtronic's ELITE studyDevice manufacturer Medtronic announced the first patient was implanted in its evaluation of InterStim Micro system performance and safety (ELITE) study.October 8, 2020AIVuno gets Korean designation for AI cardiac softwareSouth Korean artificial intelligence (AI) developer Vuno announced its AI-based cardiac arrest prediction software Vuno Med--DeepCARS has received a designation from South Korea's Ministry of Food and Drug Safety as an innovative medical device.October 8, 2020Radiation Oncology/TherapyASRT, Elekta to provide $10K for Black studentsThe American Society of Radiologic Technologists (ASRT) Foundation and radiation oncology vendor Elekta have joined forces to provide $10,000 in scholarships to improve diversity, inclusion, and representation in the healthcare industry.October 8, 2020Radiation Oncology/TherapyNew radioimmunotherapy improves lymphoma treatmentResearchers have found that a new radioimmunotherapy can reverse resistance to a common lymphoma drug, rituximab. Their findings were published in the October issue of the Journal of Nuclear Medicine.October 8, 2020Practice ManagementCMS announces new COVID-19 loan repayment termsThe U.S. Centers for Medicare and Medicaid Services (CMS) has announced new terms for repaying COVID-19 Medicare loans.October 7, 2020CTElucid's vascuCAP added to IBM Imaging AI marketplaceElucid Bioimaging's vascuCAP artificial intelligence (AI) software has been added to the IBM Imaging AI Marketplace.October 7, 2020Previous PagePage 339 of 3774Next PageTop StoriesMolecular ImagingFluciclovine PET detects disease in half of PSMA-negative patientsThe findings support a complementary role for F-18 fluciclovine PET in carefully selected patients.Clinical News5 institutions command 38% of NIH radiology research fundingMRIMRI, PET reveal distinct brain changes in loneliness and social isolationMRIPodcast: Hospital accreditation isn’t a safety net for MRISponsor ContentFREE webinar: find your imaging capacity
